Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTB101 for prevention of respiratory illness in the elderly
NCT04139915Phase 3Withdrawn
- Sponsor
- resTORbio
- Start
- Oct 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dactolisib in respiratory tract infection (RTI), sponsored by resTORbio. Planned start Oct 2019; status: withdrawn.
02
Drugs
dactolisib
03
Conditions
respiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT04139915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04139915.